Label: MUCUS RELIEF IMMEDIATE RELEASE- guaifenesin tablet

  • NDC Code(s): 69168-370-01, 69168-370-02, 69168-370-17, 69168-370-30, view more
    69168-370-41, 69168-370-60
  • Packager: Allegiant Health
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 26, 2019

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    Guaifenesin 400mg

  • Purpose

    Expectorant

  • Uses

    • helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive to rid the bronchial passageway of bothersome mucus
  • Warnings

    Ask a doctor before use if you have

    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
    • cough accompanied by excessive phlegm (mucus)

    When using this product

    • do not exceed recommended dosage
    • do not use for more than 7 days

    Stop use and ask a doctor if

    • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

    Pregnancy/Breastfeeding

    ask a health professional before use.

    Keep out of reach of children

    In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    Adults and children 12 years of age and older: take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 doses in 24 hours.

    Children under 12 years of age: do not use

  • Other information

    • store at 25°C (77°F) excursions between 15°-30°C (59°-86°F)
    • keep in a dry place and do not expose to heat
    • do not use if imprinted safety seal under cap is broken or missing
  • Inactive ingredients

    Croscarmellose Sodium, Maltodextrin, Microcrystalline Cellulose, Povidone, Silicon Dioxide, Stearic Acid

  • Questions or comments?

    Call 1-888-952-0050

    Monday through Friday 9AM - PM EST.

  • Principal Display Panel

    Mucus Relief

    Mucus Relief

  • INGREDIENTS AND APPEARANCE
    MUCUS RELIEF  IMMEDIATE RELEASE
    guaifenesin tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69168-370
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    POVIDONE (UNII: FZ989GH94E)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeROUNDSize17mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69168-370-01100 in 1 BOTTLE; Type 0: Not a Combination Product12/23/2014
    2NDC:69168-370-301 in 1 CARTON12/23/2014
    230 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:69168-370-411 in 1 CARTON12/23/2014
    315 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:69168-370-17300 in 1 BOTTLE; Type 0: Not a Combination Product03/28/2019
    5NDC:69168-370-6060 in 1 BOTTLE; Type 0: Not a Combination Product06/08/2022
    6NDC:69168-370-02150 in 1 BOTTLE; Type 0: Not a Combination Product11/06/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01212/23/2014
    Labeler - Allegiant Health (079501930)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!